Sort
64,565 grants matching “drug discovery”
Phase I IUCRC at Notre Dame: Center for Bioanalytic Metrology
$750,000Paul W Bohn · University Of Notre Dame · · FY2019 · ENG
SBIR Phase II: Development of a robust multiplex protein test for cardiovascular disease research
$750,000John Dishinger · Phasiq, Inc. · · FY2015 · TIP
Chicago D-CFAR
$750,000Alan L Landay · Rush University Medical Center · P30 · FY2009 · AI
CSR: Medium: Scale, Isolation, and Performance in Data Center Networks
$750,000George Porter · University Of California-San Diego · · FY2010 · CSE
Automated image-based biomarker computation tools for diabetic retinopathy
$750,000Kaushal Solanki · Eyenuk, Inc. · R44 · FY2018 · TR
Development of PAR2 Pepducins for the Treatment of Atopic Dermatitis
$750,000Athan Kuliopulos · Oasis Pharmaceuticals · R42 · FY2016 · AR
Automated image-based biomarker computation tools for diabetic retinopathy
$750,000Kaushal Solanki · Eyenuk, Inc. · R44 · FY2019 · TR
NIRT: Nanofluidic Networks for Single-Molecule Protein Analysis
$750,000Don L Devoe · University Of Maryland, College Park · · FY2003 · ENG
VALIDATION AND QUANTIFICATION OF FFPE ANTIGEN RETRIEVAL BY PROTEOME ANALYSIS
$750,000Satya Prakash Saxena · Calibrant Biosystems, Inc. · R42 · FY2009 · CA
MAPP Research Networdk TIssue Analysis & Technology Core
$750,000M S Lucia · University Of Colorado Denver · U01 · FY2012 · DK
Collaborative research: Quantifying the biological, chemical, and physical linkages between chemosynthetic communities and the surrounding deep sea
$750,000Lisa A Levin · University Of California-San Diego Scripps Inst Of Oceanography · · FY2016 · GEO
Gynecologic Oncology Group Specimen Banking
$750,000Philip J Disaia · Gynecologic Oncology Group · U24 · FY2012 · CA
Web Software for Drug Targeting Signaling Networks in Primary Cell Subsets
$750,000Nikesh Kotecha · Cytobank, Inc. · R44 · FY2014 · GM
Predictive assessment of acute and chronic cardiotoxicity using combinatorially matured hPSC-CMs
$750,000Nicholas Andrew Geisse · Curi Bio Inc · R44 · FY2021 · HL
SBIR Phase II: A Platform for Anthelmintic Drug Discovery using Genome-modified C. elegans
$750,000Christopher E Hopkins · Knudra Diagnostics · · FY2015 · TIP
Development of Conformation Specific Kinase Inhibitors
$750,000Sunesis Pharmaceuticals, Inc. · R44 · FY2005 · CA
A robust heterologous expression system of intact fungal secondary metabolite gene clusters for natural product discovery in Aspergillus nidulans
$750,000Chengcang Charles Wu · Intact Genomics, Inc. · R44 · FY2018 · AT
Development of PAR2 Pepducins for the Treatment of Atopic Dermatitis
$750,000Athan Kuliopulos · Oasis Pharmaceuticals · R42 · FY2017 · AR
GInAS - Global Ingredient Archival System
$750,000Noel Southall · National Center For Advancing Translational Sciences · ZIA · FY2015 · TR
Predictive assessment of acute and chronic cardiotoxicity using combinatorially matured hPSC-CMs
$750,000Nicholas Andrew Geisse · Curi Bio Inc · R44 · FY2022 · HL
An Open Web Service For Fragment-based Design of Small Molecule Inhibitors
$749,999John L Kulp · Conifer Point Pharmaceuticals, Llc · R44 · FY2018 · GM
An Open Web Service For Fragment-based Design of Small Molecule Inhibitors
$749,999John Laurence Kulp III · Conifer Point Pharmaceuticals, Llc · R44 · FY2019 · GM
SBIR Phase II: Imaging Flow Cytometer for High-Throughput High-Content Screening
$749,999Eric D Diebold · Omega Biosystems Incorporated · · FY2016 · TIP
Complex 3-Dimensional in vitro Human Skin Tissue Models for Scleroderma
$749,999Yolanda Camille Nesbeth · Celdara Medical, Llc · R44 · FY2018 · AR
A Computer Modeling Approach
$749,999Mitchell W Mutz · Amplyx Pharmaceuticals, Inc. · R44 · FY2014 · NS